Patents by Inventor Jens Olof Holmberg

Jens Olof Holmberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stabilized HIV-1 peptide constructs comprising the gp120 C5 domain and gp41 hydrophilic domain
    Patent number: 10251949
    Abstract: Disclosed is a method for treatment of HIV related diseases comprising targeting complexes between on the one hand the C5 domain of gp120 and on the other hand gp41 or the C2 domain of gp120. The complexes may be stabilised by administering compounds, such as antibodies, capable of directly interacting with and stabilising the complex, or by immunizing with C5 and gp41/C2 derived material so as to induce antibodies that bind to and stabilise the complex.
    Type: Grant
    Filed: November 25, 2015
    Date of Patent: April 9, 2019
    Assignee: BIONOR IMMUNO AS
    Inventors: Maja Sommerfelt Grønvold, Angus Dalgleish, Einar Tønnes Lange, Jens Olof Holmberg, Per Bengtsson, Birger Sørensen
  • PEPTIDE SCAFFOLD DESIGN
    Publication number: 20170112917
    Abstract: The present invention relates to novel peptides and methods for treatment, diagnosis and prognosis of virus infections including infections with HCV, HIV, CMV and Influenza. The invention further relates to methods for identifying and providing peptides useful for the treatment and diagnosis.
    Type: Application
    Filed: December 21, 2016
    Publication date: April 27, 2017
    Applicant: Bionor Immuno AS
    Inventors: Einar Tønnes Lange, Maja Sommerfelt Grønvold, Jens Olof Holmberg, Birger Sørensen
  • Peptide scaffold design
    Patent number: 9550811
    Abstract: The present invention relates to novel peptides and methods for treatment, diagnosis and prognosis of virus infections including infections with HCV, HIV, CMV and Influenza. The invention further relates to methods for identifying and providing peptides useful for the treatment and diagnosis.
    Type: Grant
    Filed: December 2, 2011
    Date of Patent: January 24, 2017
    Assignee: BIONOR IMMUNO AS
    Inventors: Einar Tønnes Lange, Maja Sommerfelt Grønvold, Jens Olof Holmberg, Birger Sørensen
  • Novel Therapeutic and Diagnostic Means
    Publication number: 20160144019
    Abstract: Disclosed is a method for treatment of HIV related diseases comprising targeting complexes between on the one hand the C5 domain of gp120 and on the other hand gp41 or the C2 domain of gp120. The complexes may be stabilised by administering compounds, such as antibodies, capable of directly interacting with and stabilising the complex, or by immunizing with C5 and gp41/C2 derived material so as to induce antibodies that bind to and stabilise the complex.
    Type: Application
    Filed: November 25, 2015
    Publication date: May 26, 2016
    Applicant: Bionor Immuno AS
    Inventors: Maja Sommerfelt GRØNVOLD, Angus DALGLEISH, Einar Tønnes LANGE, Jens Olof HOLMBERG, Per BENGTSSON, Birger SØRENSEN
  • Peptide constructs derived from the GP120 C5 domain and GP41 transmembrane domain
    Patent number: 9200065
    Abstract: Disclosed is a method for treatment of HIV related diseases comprising targeting complexes between on the one hand the C5 domain of gp120 and on the other hand gp41 or the C2 domain of gp120. The complexes may be stabilised by administering compounds, such as antibodies, capable of directly interacting with and stabilising the complex, or by immunizing with C5 and gp41/C2 derived material so as to induce antibodies that bind to and stabilise the complex.
    Type: Grant
    Filed: July 3, 2010
    Date of Patent: December 1, 2015
    Assignee: Bionor Immuno AS
    Inventors: Maja Sommerfelt Grønvold, Angus Dalgleish, Einar Tønnes Lange, Jens Olof Holmberg, Per Bengtsson, Birger Sørensen
  • PEPTIDE SCAFFOLD DESIGN
    Publication number: 20130337002
    Abstract: The present invention relates to novel peptides and methods for treatment, diagnosis and prognosis of virus infections including infections with HCV, HIV, CMV and Influenza. The invention further relates to methods for identifying and providing peptides useful for the treatment and diagnosis.
    Type: Application
    Filed: December 2, 2011
    Publication date: December 19, 2013
    Applicant: BIONOR IMMUNO AS
    Inventors: Einar Tønnes Lange, Maja Sommerfelt Grønvold, Jens Olof Holmberg, Birger Sørensen
  • Novel Therapeutic and Diagnostic Means
    Publication number: 20120263720
    Abstract: Disclosed is a method for treatment of HIV related diseases comprising targeting complexes between on the one hand the C5 domain of gp120 and on the other hand gp41 or the C2 domain of gp120. The complexes may be stabilised by administering compounds, such as antibodies, capable of directly interacting with and stabilising the complex, or by immunizing with C5 and gp41/C2 derived material so as to induce antibodies that bind to and stabilise the complex.
    Type: Application
    Filed: July 3, 2010
    Publication date: October 18, 2012
    Applicant: Bionor Immuno AS
    Inventors: Maja Sommerfelt Grønvold, Angus Dalgleish, Einar Tønnes Lange, Jens Olof Holmberg, Per Bengtsson, Birger Sørensen